Cargando…

Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening

Objectives: The negative publicity about menopausal hormone therapy (MHT) has led to increased use of complementary and alternative medicines (CAM) and non-pharmacological interventions (NPI) for menopausal symptom relief. We report on the prevalence and predictors of CAM/NPI among UK postmenopausal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gentry-Maharaj, A., Karpinskyj, C., Glazer, C., Burnell, M., Bailey, K., Apostolidou, S., Ryan, A., Lanceley, A., Fraser, L., Jacobs, I., Hunter, M. S., Menon, U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448394/ https://www.ncbi.nlm.nih.gov/pubmed/28326899 http://dx.doi.org/10.1080/13697137.2017.1301919

Ejemplares similares

Use and perceived efficacy of complementary and alternative medicines after discontinuation of hormone therapy: a nested United Kingdom Collaborative Trial of Ovarian Cancer Screening cohort study
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2015)

Serial endometrial thickness and risk of non‐endometrial hormone‐dependent cancers in postmenopausal women in UK Collaborative Trial of Ovarian Cancer Screening
por: Burnell, M., et al.
Publicado: (2020)

Validity of self-reported hysterectomy: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2014)

Concordance of National Cancer Registration with self-reported breast, bowel and lung cancer in England and Wales: a prospective cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Gentry-Maharaj, A, et al.
Publicado: (2013)

Risk of chronic liver disease in post-menopausal women due to body mass index, alcohol and their interaction: a prospective nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Trembling, Paul M, et al.
Publicado: (2017)

Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2017)

Ovarian cancer symptoms, routes to diagnosis and survival – Population cohort study in the ‘no screen’ arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Dilley, James, et al.
Publicado: (2020)

Association between skirt size and chronic liver disease in post-menopausal women: a prospective cohort study within the United Kingdom Trial of Ovarian Cancer Screening (UKCTOCS)
por: Trembling, P. M., et al.
Publicado: (2018)

Socioeconomic indicators of health inequalities and female mortality: a nested cohort study within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Bailey, Katharine, et al.
Publicado: (2015)

Histological confirmation of breast cancer registration and self-reporting in England and Wales: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening
por: Fourkala, E O, et al.
Publicado: (2012)

Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Thomas, Darren S., et al.
Publicado: (2019)

Socioeconomic Status and Ovarian Cancer Stage at Diagnosis: A Study Nested Within UKCTOCS
por: Karpinskyj, Chloe, et al.
Publicado: (2020)

Association of skirt size and postmenopausal breast cancer risk in older women: a cohort study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Fourkala, Evangelia-Ourania, et al.
Publicado: (2014)

Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Kalsi, Jatinderpal, et al.
Publicado: (2021)

UKCTOCS update: applying insights of delayed effects in cancer screening trials to the long-term follow-up mortality analysis
por: Burnell, Matthew, et al.
Publicado: (2021)

Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

Long-Term Secondary Care Costs of Endometrial Cancer: A Prospective Cohort Study Nested within the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Pennington, Mark, et al.
Publicado: (2016)

Cancer-associated autoantibodies to MUC1 and MUC4—A blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening
por: Pedersen, Johannes W, et al.
Publicado: (2014)

Complementary and Alternative Medicine for Menopause
por: Johnson, Alisa, et al.
Publicado: (2019)

Audit of transvaginal sonography of normal postmenopausal ovaries by sonographers from the United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Stott, Will, et al.
Publicado: (2018)

Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Sharma, A., et al.
Publicado: (2016)

Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials—an ovarian cancer exemplar
por: Kalsi, Jatinderpal K., et al.
Publicado: (2021)

The Enhanced Liver Fibrosis test is associated with liver-related outcomes in postmenopausal women with risk factors for liver disease
por: Trembling, Paul M., et al.
Publicado: (2020)

Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Menon, Usha, et al.
Publicado: (2021)

Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
por: Jacobs, Ian J, et al.
Publicado: (2016)

Evaluation of serum CEA, CYFRA21-1 and CA125 for the early detection of colorectal cancer using longitudinal preclinical samples
por: Thomas, D S, et al.
Publicado: (2015)

The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
por: Menon, Usha, et al.
Publicado: (2017)

Early detection of cancer in the general population: a blinded case–control study of p53 autoantibodies in colorectal cancer
por: Pedersen, J W, et al.
Publicado: (2013)

The use of complementary and alternative medicine by women experiencing menopausal symptoms in Bologna
por: Cardini, Francesco, et al.
Publicado: (2010)

Complementary and alternative treatment methods for menopausal hot flashes used in Turkey
por: Ozcan, Handan, et al.
Publicado: (2019)

The Perils of Complementary Alternative Medicine
por: Bayme, Michael J., et al.
Publicado: (2014)

Multi-Marker Longitudinal Algorithms Incorporating HE4 and CA125 in Ovarian Cancer Screening of Postmenopausal Women
por: Gentry-Maharaj, Aleksandra, et al.
Publicado: (2020)

An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer
por: Teschendorff, Andrew E., et al.
Publicado: (2009)

Association of adult attachment with delays in accessing specialist care in women with ovarian cancer
por: Datta, Soumitra Shankar, et al.
Publicado: (2022)

Ageing and menopause considerations for women with HIV in the UK
por: Sherr, L, et al.
Publicado: (2016)

Discovery of serum biomarkers of ovarian cancer using complementary proteomic profiling strategies
por: Timms, John F., et al.
Publicado: (2014)

Pharmacologic and Complementary and Alternative Medicine Therapies for Irritable Bowel Syndrome
por: Chey, William D., et al.
Publicado: (2011)

Social and Cultural Factors Affecting Complementary and Alternative Medicine (CAM) Use during Menopause in Sydney and Bologna
por: van der Sluijs, Corinne, et al.
Publicado: (2013)

Menopause symptoms in women and its relation with using complementary and alternative medicines: A survey in southeast Iran
por: Dehghan, Mahlagha, et al.
Publicado: (2022)

Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women
por: Fourkala, Evangelia-Ourania, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_lqdih8euieatqo9a16dhu1ci0s